Mckesson Corp
NYSE:MCK
P/OCF
Price to OCF
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
Market Cap | P/OCF | ||||
---|---|---|---|---|---|
US |
Mckesson Corp
NYSE:MCK
|
69.6B USD | 19.9 | ||
US |
Cencora Inc
NYSE:COR
|
45.7B USD | 11.2 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 10.9 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
24.9B USD | 6.3 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 17.8 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | -320.2 | |
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
57.6B CNY | 17.4 | ||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
60.6B HKD | 4.7 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.1B EUR | 17.2 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51B CNY | 9.8 | |
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 11.7 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.